Abstract: An antibacterial compound of formula I, wherein X is selected from fluoro or bromo, effective against Gram negative and Gram positive bacteria, and in particular against non-fermenting multiresistant bacteria affecting patients suffering from cystic fibrosis and which are responsible of severe hospital-acquired infections in immunodepressed patients; its preparation process and pharmaceutical composition comprising said compound.
Type:
Grant
Filed:
August 9, 2017
Date of Patent:
December 8, 2020
Assignees:
CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICENT), UNIVERSIDAD NACIONAL DE LA PLATA (UNLP), QUAID-I-AZAM UNIVERSITY
Abstract: The present application relates to a compound of formula (I) The present application also relates to synthesizing the compound of formula I and treating a patient with the compound of formula I having a neuropsychiatric illnesses such as a depressive disorder, schizophrenia; alcohol, nicotine, and morphine withdrawal induced depression and hyperalgesia; neuropathic pain caused by anticancerous drugs; diabetic neuropathic pain; obsessive compulsive disorder; alcohol withdrawal syndrome; static and dynamic allodynia in diabetic and cancer patients on anticancer therapy and chronic pain therapy.
Type:
Grant
Filed:
October 13, 2017
Date of Patent:
October 9, 2018
Assignees:
COMSATS Institute of Information Technology, Quaid-I-Azam University
Inventors:
Aamer Saeed, Khalid Rauf, Yasser M S A Alkahraman